First Edition
Letter
January 21 2020
Long-term outcomes of Sleeping Beauty generated CD19specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas
Samer Srour,Harjeet Singh,Jessica McCarty,Eleanor de Groot,Helen Huls,Gabriela Rondon,Muzaffar H Qazilbash,Stefan O. Ciurea,Geraldine Bardelli,Jill Buck,Amin Alousi,Yago Nieto,Katy Rezvani,David Marin,Uday Popat,Chitra Hosing,Elizabeth J Shpall,William George Wierda,Hagop Kantarjian,Richard Champlin,Laurence Cooper,Partow Kebriaei
Research Article
January 21 2020
Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations
Research Article
January 21 2020
Progressive or Relapsed Burkitt Lymphoma or Leukemia in Children and Adolescents after BFM-type First-line Therapy
Research Article
January 17 2020
How I assess and manage the risk of bleeding during treatment of patients with venous thromboembolism
Letter
January 17 2020
Multiple BCL2 mutations co-occurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
Research Article
January 16 2020
Brentuximab vedotin with chemotherapy for Stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study
David J. Straus,Monika Długosz-Danecka,Sergеу Alekseev,Arpad Illes,Marco Picardi,Ewa Lech-Maranda,Tatyana Feldman,Piotr Smolewski,Kerry J. Savage,Nancy L. Bartlett,Jan Walewski,Radhakrsihnan Ramchandren,Pier Luigi Zinzani,Martin Hutchings,Joseph M. Connors,John Radford,Javier Munoz,Won S Kim,Ranjana Advani,Stephen M. Ansell,Anas Younes,Harry Miao,Rachael Liu,Keenan Fenton,Andres Forero,Andrea Gallamini
Review Article
January 15 2020
Virus specific T-cell Therapies for Patients with Primary Immune Deficiency
Review Article
January 15 2020
Increased activation of PI3 kinase-δ predisposes to B cell lymphoma.
Research Article
January 14 2020
High-Parametric Evaluation of Human Invariant Natural Killer T Cells to Delineate Heterogeneity in Allo- and Autoimmunity
Research Article
January 13 2020
IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution
Research Article
January 13 2020
Improved transplant survival and long-term disease outcome in children with MHC class II deficiency
Su Han Lum,Claire Anderson,Peter McNaughton,Karin Regine Engelhardt,Brigid MacKenzie,Helen Watson,Hamoud A Al-Mousa,Waleed Al Herz,Bandar Al-Saud,Reem Mohammed,Daifulah M Al-Zahrani, Assistant prof.,Hamza AlGhamdi,Loie Goronfolah,Zohreh Nademi,Sahar Habibollah,Aisling M Flinn,Benjamin Shillitoe,Stephen Owens,Eleri Williams,Marieke Emonts,Sophie Hambleton,Mario Abinun,Terence Flood,Andrew Cant,Andrew R Gennery,Mary Slatter
Research Article
January 13 2020
External Validation of Models for KIR2DS1/KIR3DL1-informed Selection of Hematopoietic Cell Donors fails
Johannes Schetelig,Henning Baldauf,Falk Heidenreich,Carolin Massalski,Sandra Frank,Jürgen Sauter,Matthias Stelljes,Francis Ayuk,Wolfgang Andreas Bethge,Gesine Bug,Stefan Klein,Sarah Wendler,Vinzenz Lange,Liesbeth C. de Wreede,Daniel Fuerst,Guido Kobbe,Hellmut D Ottinger,Dietrich W. Beelen,Joannis Mytilineos,Katharina Fleischhauer,Alexander H Schmidt,Martin Bornhauser
Research Article
January 13 2020
Molecular MRD status and outcome after transplantation in NPM1 mutated AML: results from the UK NCRI AML17 study
Richard Dillon,Robert K Hills,Sylvie D Freeman,Nicola Potter,Jelena Jovanovic,Adam Ivey,Anju Shankar Kanda,Manohursingh Runglall,Nicola Foot,Mikel Valganon,Asim Khwaja,Jamie Cavenagh,Matthew L Smith,Hans Beier Ommen,Ulrik Overgaard,Mike Dennis,Steven Knapper,Harpreet Kaur,David C Taussig,Priyanka Mehta,Kavita Raj,Igor Novitzky-Basso,Emmanouil Nikolousis,Robert D Danby,Pramila Krishnamurthy,Kate Hill,Damian Finnegan,Samah Alimam,Erin Hurst,Peter Johnson,Anjum Bashir Khan,Rahuman Salim,Charles F Craddock,Ruth Lilian Spearing, Dr,Amanda Frances Gilkes,Rosemary E Gale,Alan Kenneth Burnett, -,Nigel H. Russell,David Grimwade
Research Article
January 13 2020
Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis
Letter
January 13 2020
Prevalence and disease predisposition of p.A91V perforin in an aged Caucasian population
Research Article
January 13 2020
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
Courtney D. DiNardo,Ing Soo Tiong,Anna Quaglieri,Sarah MacRaild,Sanam Loghavi,Fiona C Brown,Rachel Thijssen,Giovanna Pomilio,Adam Ivey,Jessica Salmon,Christina Glytsou,Shaun Alan Fleming,Qi Zhang,Helen Ma,Keyur P Patel,Steven M Kornblau,Zhen Xu,Chong Chyn Chua,X Chen,Piers Blombery,Christoffer Flensburg,Nik Cummings,Iannis Aifantis,Hagop Kantarjian,David Ching Siang Huang, Professor,Andrew W. Roberts,Ian J Majewski,Marina Konopleva,Andrew H Wei
Research Article
January 13 2020
Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab
Review Article
January 9 2020
Managing Thromboembolic Risk in Patients with Hereditary and Acquired Thrombophilias
Review Article
January 9 2020
Novel Antithrombotic Strategies for Treatment of Venous Thromboembolism
Review Article
January 9 2020
ACUTE TREATMENT OF VENOUS THROMBOEMBOLISM
Review Article
January 9 2020
Treatment of unusual thrombotic manifestations
Editorial
January 9 2020
Introduction to a review series on the treatment of venous thrombotic disorders
Review Article
January 9 2020
Treatment of venous thromboembolism in pediatric patients
Review Article
January 9 2020
Long-term treatment of venous thromboembolism
Research Article
January 3 2020
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia
Letter
January 2 2020
Achieving Complete Remission in CLL Patients Treated with Ibrutinib: Clinical Significance and Predictive Factors
Research Article
January 2 2020
How I treat Anemia in Heart Failure
Brief Report
December 27 2019
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia patients treated in the ALFA0701 trial
Elise Fournier,Nicolas Duployez,Benoit Ducourneau,Emmanuel Raffoux,Pascal Turlure,Denis Caillot,Xavier Thomas,Alice Marceau-Renaut,Sylvain P Chantepie,Jean-Valère Malfuson,Emilie Lemasle,Meyling H Cheok,Karine Celli-Lebras,Estelle Guerin,Christine Terré,Juliette Lambert,Cecile Pautas,Hervé Dombret,Sylvie Castaigne,Claude Preudhomme,Nicolas Boissel
Research Article
December 27 2019
Pathogenic Bhlhe40+ GM-CSF+ CD4+ T Cells Promote Indirect Alloantigen Presentation in the GI Tract during GVHD
Research Article
December 26 2019
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results
John C. Byrd,William George Wierda,Anna Schuh,Stephen Devereux,Jorge M. Chaves,Jennifer R. Brown,Peter Hillmen,Peter Martin,Farrukh T. Awan,Deborah M. Stephens,Paolo Ghia,Jacqueline Barrientos,John M. Pagel,Jennifer A. Woyach,Kathleen Burke,Todd Covey,Michael Gulrajani,Ahmed Hamdy,Raquel Izumi,Melanie M. Frigault,Priti Patel,Wayne Rothbaum,Min Hui Wang,Susan O'Brien,Richard R. Furman
Research Article
December 26 2019
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study
Simona Soverini,Luana Bavaro,Caterina De Benedittis,Margherita Martelli,Alessandra Iurlo,Nicola Orofino,Simona Sica,Federica Sora,Francesca Lunghi,Fabio Ciceri,Sara Galimberti,Claudia Baratè,Massimiliano Bonifacio,Luigi Scaffidi,Fausto Castagnetti,Gabriele Gugliotta,Francesco Albano,Antonella Vita Russo Rossi,Fabio Stagno,Francesco Di Raimondo,Mariella D'Adda,Eros Di Bona,Elisabetta Abruzzese,Gianni Binotto,Rosaria Sancetta,Marzia Salvucci,Isabella Capodanno,Mariella Girasoli,Sabrina Coluzzi,Immacolata Attolico,Caterina Musolino,Elisabetta Calistri,Mario Annunziata,Monica Bocchia,Stefania Stella,Anna Serra,Santa Errichiello,Giuseppe Saglio,Fabrizio Pane,Paolo G Vigneri,Flavio Mignone,Maria Antonella Laginestra,Stefano A Pileri,Antonio Percesepe,Elena Tenti,Gianantonio Rosti,Michele Baccarani,Michele Cavo,Giovanni Martinelli
Brief Report
December 23 2019
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer. A case-control study.
Valerio De Stefano,Arianna Ghirardi,Arianna Masciulli,Alessandra Carobbio,Francesca Palandri,Nicola Vianelli,Elena Rossi,Silvia Betti,Ambra Di Veroli,Alessandra Iurlo,Daniele Cattaneo,Guido Finazzi,Massimiliano Bonifacio,Luigi Scaffidi,Andrea Patriarca,Elisa Rumi,Ilaria Carola Casetti,Clemency Imogen Methven Stephenson,Paola Guglielmelli,Elena Maria Elli,Miroslava Palova,Davide Rapezzi,Daniel Erez,Montse Gomez,Kai Wille,Manuel Perez-Encinas,Francesca Lunghi,Anna Angona,María-Laura Fox,Eloise Beggiato,Giulia Benevolo,Giuseppe Carli,Rossella Cacciola,Mary Frances McMullin,Alessia Tieghi,Valle Recasens,Susanne Isfort,Monia Marchetti,Martin Griesshammer,Alberto Alvarez-Larran,Alessandro Maria Vannucchi,Alessandro Rambaldi,Tiziano Barbui
Research Article
December 19 2019
Pluripotent stem cell-derived NK cells with high-affinity non-cleavable CD16a mediate improved anti-tumor activity
Advertisement
Advertisement
